DE69201463T2 - Diagnostisches Verfahren. - Google Patents

Diagnostisches Verfahren.

Info

Publication number
DE69201463T2
DE69201463T2 DE69201463T DE69201463T DE69201463T2 DE 69201463 T2 DE69201463 T2 DE 69201463T2 DE 69201463 T DE69201463 T DE 69201463T DE 69201463 T DE69201463 T DE 69201463T DE 69201463 T2 DE69201463 T2 DE 69201463T2
Authority
DE
Germany
Prior art keywords
serum
multiple sclerosis
prosomal
immunochemical
diagnostic procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69201463T
Other languages
English (en)
Other versions
DE69201463D1 (de
Inventor
Klaus Scherrer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Pro-Soma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro-Soma filed Critical Pro-Soma
Application granted granted Critical
Publication of DE69201463D1 publication Critical patent/DE69201463D1/de
Publication of DE69201463T2 publication Critical patent/DE69201463T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/285Demyelinating diseases; Multipel sclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Electrotherapy Devices (AREA)
  • Detergent Compositions (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Electric Propulsion And Braking For Vehicles (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Vehicle Body Suspensions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69201463T 1991-06-21 1992-05-26 Diagnostisches Verfahren. Expired - Fee Related DE69201463T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91401443 1991-06-21

Publications (2)

Publication Number Publication Date
DE69201463D1 DE69201463D1 (de) 1995-03-30
DE69201463T2 true DE69201463T2 (de) 1995-06-14

Family

ID=8208577

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69201463T Expired - Fee Related DE69201463T2 (de) 1991-06-21 1992-05-26 Diagnostisches Verfahren.

Country Status (13)

Country Link
US (1) US5472848A (de)
EP (1) EP0519536B1 (de)
JP (1) JP3225248B2 (de)
KR (1) KR930000951A (de)
AT (1) ATE118893T1 (de)
AU (1) AU656198B2 (de)
CA (1) CA2069546C (de)
DE (1) DE69201463T2 (de)
DK (1) DK0519536T3 (de)
ES (1) ES2072083T3 (de)
FI (1) FI104219B1 (de)
IE (1) IE66243B1 (de)
ZA (1) ZA923679B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030092089A1 (en) * 2001-11-14 2003-05-15 Moscarello Mario Anthony Method for diagnosing multiple sclerosis and an assay therefore
EP1597557A4 (de) * 2002-10-11 2008-06-11 Univ California Verfahren zur diagnose und prognose von multipler sklerose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807532A (nl) * 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
US4533496A (en) * 1984-05-08 1985-08-06 Monsanto Company Method of isolating monoclonal antibodies from hybridoma cultures
FR2586814A1 (fr) * 1985-08-30 1987-03-06 Centre Nat Rech Scient Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules
US4859612A (en) * 1987-10-07 1989-08-22 Hygeia Sciences, Inc. Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite
JPH01309686A (ja) * 1988-06-08 1989-12-14 Otsuka Pharmaceut Co Ltd 多機能プロテアーゼ
JPH05503712A (ja) * 1990-10-11 1993-06-17 プロ―ソマ・サルル 診断方法

Also Published As

Publication number Publication date
FI104219B (fi) 1999-11-30
FI922480A0 (fi) 1992-05-29
US5472848A (en) 1995-12-05
AU656198B2 (en) 1995-01-27
FI104219B1 (fi) 1999-11-30
AU1829892A (en) 1992-12-24
DK0519536T3 (da) 1995-06-06
CA2069546C (en) 2005-08-16
FI922480A (fi) 1992-12-22
EP0519536A1 (de) 1992-12-23
JP3225248B2 (ja) 2001-11-05
JPH0694707A (ja) 1994-04-08
ATE118893T1 (de) 1995-03-15
KR930000951A (ko) 1993-01-16
DE69201463D1 (de) 1995-03-30
ZA923679B (en) 1993-01-27
IE922001A1 (en) 1992-12-30
CA2069546A1 (en) 1992-12-22
EP0519536B1 (de) 1995-02-22
ES2072083T3 (es) 1995-07-01
IE66243B1 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
GB1475125A (en) Immunological detection
DK155967C (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
US4092114A (en) Indirect latex test for determination of immunoglobulins
Watanabe et al. Enzyme immunoassay for human ferritin.
GR3005971T3 (de)
ATE118893T1 (de) Diagnostisches verfahren.
EP0387027A3 (de) Methode und Reagenz zur Diagnose von Endometriose
ATE229037T1 (de) Monoklonaler antikörper gegen denthrombin- antithrombin iii-komplex und dessen verwendung in immunoassays
ATE174688T1 (de) Verfahren zur bestimmung von antigenen oder antikörpern in gegenwart eines immunkomplexes
EP0040020A3 (de) Menschliches Reverse-Transcriptase-Enzym, Verfahren zu seiner Reinigung und seine Verwendung zum Nachweis von Brustkrebs
ATE14161T1 (de) Verfahren zur bestimmung von immunkomplexen.
GR940300091T1 (en) Equipment and test for determining an antigen/antibody in a test sample.
DE3781181D1 (de) Reagenz mit monoklonalantikoerpern zu bakteroides gingivalis.
EP0096520A3 (de) Antigennachweis:Rheumatoide Arthritis
ATE64466T1 (de) Immuntest.
JPH0547781B2 (de)
HUT62705A (en) Method for detecting illneses by means of blood-serum test

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOMERIEUX, MARCY L'ETOILE, FR

8327 Change in the person/name/address of the patent owner

Owner name: BIOMERIEUX, MARCY L'ETOILE, FR

8339 Ceased/non-payment of the annual fee